The latest data of "IDF Diabetes Map" is released! The "Diabetes Reserve Army" numbers are staggering for 2022EASD

The latest data from the International Diabetes Alliance (IDF) Diabetes Map released by this conference shows that in 2021, the global prevalence of impaired glucose tolerance (IGT) in adults will be 9.

464 million, the "diabetic reserve army" number is amazing!

Although diabetes is not diagnosed, once it enters prediabetes, it also means that the health risk is significantly increased

For countries without domestic data, the values are inferred

The global prevalence of IGT in 2021 is 9.

Note: HIC: Higher Income Countries; MIC: Middle-Income Countries; LIC: Low-Income Countries

Figure 1 Global IGT Prevalence (Forecast to 2021 and 2045)

The global prevalence of IFG in 2021 is 5.

Note: HIC: Higher Income Countries; MIC: Middle-Income Countries; LIC: Low-Income Countries

Figure 2 Global IFG prevalence (2021 and 2045 projections)

➤ The prevalence of IGT and IFG is highest in high-income

The current state of the global diabetes epidemic: 16% increase in two years! One in ten adults develop diabetes

Previously published data show that the number of adult diabetics worldwide will reach 537 million (10.

Globally, the number of people with diabetes in 2021: the Western Pacific is up to 206 million, Southeast Asia is 90 million, the Middle East and North Africa is 73 million, Europe is 61 million, North America and the Caribbean is 51 million, South America and Central America is 32 million, and Africa is 24 million
.

Figure 3 Global diabetes map in 2021

Figure 4 Total number of adults with diabetes (aged 20-79 years) in 2021

China Diabetes Report (2000-2045): 50% increase in 10 years, half of patients are not yet aware

The new version of the IDF map data shows that in the past 10 years (2011 to 2021), the number of diabetic patients in China has increased from 90 million to 140 million, an increase of 56%, of which about 72.
83 million patients have not yet been diagnosed, the proportion is as high as 51.
7%.

In the next 20 years, although the increase in the prevalence of diabetes in China will tend to decline, the total number of patients will increase to 164 million in 2030 and 175 million
in 2045.

Figure 5 Diabetes report in China from 2000 to 2045

The current situation of "pre-diabetic" patients in China

➤ Impaired glucose tolerance (IGT): In 2021, about 170 million adults in China will have IGT, an increase of 6 times
compared with 2011.

➤ Fasting blood glucose damage (IFG): In 2021, about 27 million adults in China will have IFG, and this number may increase to about 30 million
in 2045.

The prevalence of "type 1 diabetes" in China

➤ Number of new onset of type 1 diabetes: In 2021, the number of new outbreaks of type 1 diabetes in China will be 0.
49 million for 0-14 years old and 0.
61 million for 0-19 years old;

➤ Number of type 1 diabetes patients: In 2021, the number of people with type 1 diabetes in China will be 29,600 from 0-14 years old and 56,000 from 0-19 years old
.

The prevalence of "gestational hyperglycemia" in China

In 2021, the prevalence of gestational diabetes in China was 8.
6%, and the number of live births affected by hyperglycemia during pregnancy alone was as high as more than 8.
7 million, of which the number of live births affected by other types of diabetes was found for the first time during pregnancy exceeded 1 million
.

Table 2 Diabetes Report in China (2000-2045)

Summary of this article

In summary, the global prevalence of diabetes and prediabetes is still on the rise, and the increase is large, the health burden caused by diabetes is still a major challenge for individuals, families and society, and there is an urgent need to implement interventions to delay and stop growth
.